Fallopian tube primary cancer: report of five cases and review of the literature

Objective: The aim of this retrospective study was to analyze the clinical characteristics, management and prognosis of five patients with fallopian tube primary cancer (FTPC) who were diagnosed and treated in our departments. A review of the current literature is also presented. Materials and methods: Between January 2000 and August 2009, five cases with histologically confirmed FTPC were diagnosed in our departments and were then evaluated retrospectively. All patients underwent total abdominal hysterectomy with bilateral salpingo-oophorectomy and total omentectomy. Results: We had two patients in Stage IA (40%), two patients in Stage IC (40%) and one patient in Stage IIIA (20%). All patients received adjuvant chemotherapy with platinum-based combinations and two of them received additional radiotherapy. Conclusion: FTPC, compared with ovarian primary cancer (OPC), is more likely to present at an early stage and have an overall more favourable outcome. More extensive clinical research must be performed to have definite aetiologic, diagnostic and management modalities.

Fallopian tube cancer; Treatment; Chemotherapy; Prognosis

[1] Brown M.D., Kohorn E.I., Kapp D.S., Schwartz P.E., Merino M.: “Fallopian tube carcinoma”. Int. J. Radiat. Oncol. Biol. Phys., 1985, 11, 583.

[2] Riska A., Leminen A., Pukkala E.: “Sociodemographic determinants of incidence of primary fallopian tube carcinoma, Finland 1953-97”. Int. J. Cancer, 2003, 104, 643.

[3] McMurray E.H., Jacobs A.J., Perez C.A., Camel H.M., Kao M.S., Galakatos A.: “Carcinoma of the fallopian tube. Management and sites of failure”. Cancer, 1986, 58, 2070.

[4] Rosenblatt K.A., Weiss N.S., Schwartz S.M.: “Incidence of malignant fallopian tube tumours”. Gynecol. Oncol., 1989, 35, 236.

[5] Kourea H.P., Adonakis G., Androutsopoulos G., Zili P., Kourounis G., Decavalas G.: “Fallopian tube malignant mixed müllerian tumour (carcinosarcoma): a case report with immunohistochemical profiling”. Eur. J. Gynaecol. Oncol., 2008, 29, 538.

[6] Nordin A.J.: “Primary carcinoma of the fallopian tube: a 20-year literature review”. Obstet. Gynecol. Surv., 1994, 49, 349.

[7] Pectasides D., Pectasides E., Economopoulos T.: “Fallopian tube carcinoma: a review”. Oncologist, 2006, 11, 902.

[8] Ajithkumar T.V., Minimole A.L., John M.M., Ashokkumar O.S.: “Primary fallopian tube carcinoma”. Obstet. Gynecol. Surv., 2005, 60, 247.

[9] Hu C.Y., Taymor M.L., Hertig A.T.: “Primary carcinoma of the fallopian tube”. Am. J. Obstet. Gynecol., 1950, 59, 58.

[10] Obermair A., Taylor K.H., Janda M., Nicklin J.L., Crandon A.J., Perrin L.: “Primary fallopian tube carcinoma: the Queensland experience”. Int. J. Gynecol. Cancer, 2001, 11, 69.

[11] Huber-Buchholz M.M., Buchholz N.P., Staehelin J.: “Analysis of 23 cases of primary carcinoma of the fallopian tube over 50 years”.J. Obstet. Gynaecol. Res., 1996, 22, 193.

[12] Meng M.L., Gan-Gao, Scheng-Sun, Bao Q.C., Jung Z.A.: “Diagnosis of primary adenocarcinoma of the fallopian tube”. J. Cancer Res. Clin. Oncol., 1985, 110, 136.

[13] Henderson S.R., Harper R.C., Salazar O.M., Rudolph J.H.: “Primary carcinoma of the fallopian tube: difficulties of diagnosis and treatment”. Gynecol. Oncol., 1977, 5, 168.

[14] Sedlis A.: “Carcinoma of the fallopian tube”. Surg. Clin. North Am., 1978, 58, 121.

[15] Heintz A.P., Odicino F., Maisonneuve P., Beller U., Benedet J.L.., Creasman W.T., Ngan H.Y., Sideri M., Pecorelli S.: “Carcinoma of the fallopian tube”. J. Epidemiol. Biostat., 2001, 6, 89.

[16] Baekelandt M., Jorunn Nesbakken A., Kristensen G.B., Tropé C. G., Abeler V.M.: “Carcinoma of the fallopian tube”. Cancer, 2000, 89, 2076.

[17] Kurjak A., Kupesic S., Ilijas M., Sparac V., Kosuta D.: “Preoperative diagnosis of primary fallopian tube carcinoma”. Gynecol. Oncol., 1998, 68, 29.

[18] Kurjak A., Kupesic S., Jacobs I.: “Preoperative diagnosis of the primary fallopian tube carcinoma by three-dimensional static and power Doppler sonography”. Ultrasound Obstet. Gynecol., 2000, 15, 246.

[19] Kawakami S., Togashi K., Kimura I., Nakano Y., Koshiyama M., Takakura K. et al.: “Primary malignant tumour of the fallopian tube: appearance at CT and MR imaging”. Radiology, 1993, 186, 503.

[20] Hefler L.A., Rosen A.C., Graf A.H., Lahousen M., Klein M., Leodolter S. et al.: “The clinical value of serum concentrations of cancer antigen 125 in patients with primary fallopian tube carcinoma: a multicenter study”. Cancer, 2000, 89, 1555.

[21] Puls L.E., Davey D.D., DePriest P.D., Gallion H.H., van Nagell J.R. Jr, Hunter J.E., Pavlik E.J.: “Immunohistochemical staining for CA-125 in fallopian tube carcinomas”. Gynecol. Oncol., 1993, 48, 360.

[22] Alvarado-Cabrero I., Young R.H., Vamvakas E.C., Scully R.E.: “Carcinoma of the fallopian tube: a clinicopathological study of 105 caseswith observations on staging and prognostic factors”. Gynecol. Oncol., 1999, 72, 367.

[23] Yoonessi M.: “Carcinoma of the fallopian tube”. Obstet. Gynecol. Surv., 1979, 34, 257.

[24] Tamimi H.K., Figge D.C.: “Adenocarcinoma of the uterine tube: potential for lymph node metastases”. Am. J. Obstet. Gynecol., 1981, 141, 132.

[25] Rosen A.C., Klein M., Hafner E., Lahousen M., Graf A.H., Reiner A.: “Management and prognosis of primary fallopian tube carcinoma: Austrian Cooperative Study Group for Fallopian Tube Carcinoma”. Gynecol. Obstet. Invest., 1999, 47, 45.

[26] Gadducci A., Landoni F., Sartori E., Maggino T., Zola P., Gabriele A. et al.: “Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study”. Gynecol. Oncol., 2001, 81, 150.

[27] Gadducci A.: “Current management of fallopian tube carcinoma”. Curr. Opin. Obstet. Gynecol., 2002, 14, 27.

[28] Klein M., Rosen A., Lahousen M., Graf A.H., Rainer A.: “The relevance of adjuvant therapy in primary carcinoma of the fallopian tube, Stages I and II: irradiation vs chemotherapy”. Int. J. Radiat. Oncol. Biol. Phys., 2000, 48, 1427.

[29] Schray M.F., Podratz K.C., Malkasian G.D.: “Fallopian tube cancer: the role of radiation therapy”. Radiother. Oncol., 1987, 10, 267.

[30] Peters W.A. 3rd, Andersen W.A., Hopkins M.P., Kumar N.B., Morley G.W.: “Prognostic features of carcinoma of the fallopiantube”. Obstet. Gynecol., 1988, 71, 757.

[31] Wethington S.L., Herzog T.J., Seshan V.E., Bansal N., Schiff P.B., Burke W.M. et al.: “Improved survival for fallopian tube cancer: a comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer”. Cancer, 2008, 113, 3298.

[32] Kosary C., Trimble E.L.: “Treatment and survival for women with Fallopian tube carcinoma: a population-based study”. Gynecol. Oncol., 2002, 86, 190.